Effect of Long Protocol versus Short Protocol of Metformin Therapy in Pregnancy Outcomes in Polycystic Ovarian Syndrome - A Comparative Study

No abstract is available for this paper.

• Publication year

  2016

• Venue

  journal of medical science and clinical research

• Publication date

  2016-05-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.18535/JMSCR/V4I5.21
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study.

  2010cited by this paper
• Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome?

  2008cited by this paper
• Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome.

  2005cited by this paper
• Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study.

  2004cited by this paper
• Pregnancy outcome in women with PCOS and in controls matched by age and weight.

  2003cited by this paper
• Metformin and gestational diabetes

  2003cited by this paper
• Metformin and intervention in polycystic ovary syndrome. Endocrine Society of Australia, the Australian Diabetes Society and the Australian Paediatric Endocrine Group.

  2001cited by this paper
• Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.

  2000cited by this paper
• Correction of hyperinsulinemia in oligoovulatory women with clomiphene-resistant polycystic ovary syndrome: a review of therapeutic rationale and reproductive outcomes.

  2000cited by this paper
• Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome.

  1999cited by this paper
• Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.

  1999cited by this paper
• Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome.

  1998cited by this paper
• Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome.

  1997cited by this paper
• Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Evidence for Distinctive and Intrinsic Defects in Insulin Action in Polycystic Ovary Syndrome

  1992cited by this paper
• Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome

  1989cited by this paper

• No citing papers are available for this paper.